InsidersTradesSigma
Follow the AntriaBio, Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 11 January 2016 (Cession). Among the most active insiders: Elam Nevan C. Every trade is openly available.
Analysts rate AntriaBio, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
AntriaBio, Inc. 是一家生物制药公司，专注于开发糖尿病及其他代谢疾病的治疗方法。该公司在纳斯达克上市，股票代码为 ABIO。